human primitive mesenchymal stem cells (Tianjin Maidisen Regenerative Medicine)

N/A

Report date: 2025/01/26 18:00:30

Base Information

Drug Namehuman primitive mesenchymal stem cells (Tianjin Maidisen Regenerative Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Madison Regenerative Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Madison Regenerative Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A